You may leave me a review on these links:

Dr Tristan Barnes

  • BSc (Med) MB BS (Hons I) FRACP
  • Medical Oncologist
  • Spoken languages English


It is a privilege to meet and help people through a difficult journey and strive with them for the best possible outcomes

Awards received

  • Clinical Research Fellowship 2017 University of Toronto (Princess Margaret Cancer Centre)

Professional memberships

  • American Society Clinical Oncology
  • Clinical Oncology Society of Australia
  • International Association for the Study of Lung Cancer
  • Royal Australian College of Physicians
  • Australian and New Zealand Breast Cancer Trials Group

Publications and affiliations

  • Barnes TA, Albaba A et al; Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience; The Oncologist Aug 2019 2019;24:1–9
  • Goldvaser H,Barnes TA, Cescon DW, Ocaña A, Ribnikar D, Amir E; Toxicity of Extended Adjuvant Therapy with Aromatase Inhibitors in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis; JNCI August 2017;
  • Barnes TA, Leighl NB. Expanding therapies for crizotinib refractory ALK-rearranged non-small cell lung cancer. Transl Cancer Res 2016;5 (Suppl 3):S458-S461. http://doi:10.21037/tcr.2016.09.11.
  • Barnes TA, Amir E. Minireivew – Hype or Hope: The role of infiltrating immune cells in Cancer; British Journal of Cancer 2017 Jul 13; doi: 10.1038/bjc.2017.220
  • Barnes TA, Amir E, Templeton AJ, Gomez Garcia S, Navarro B, Seruga B, Ocana A. Efficacy, Safety, Tolerability and Price of Newly Approved Drugs in Solid Tumors; Cancer Treatment Reviews 2017 Apr 9;56:1-7 DOI: 10.1016/j.ctrv.2017.03.011